Cancer Institute A national cancer institute
designated cancer center

August 2010 Cancer Center Bulletin

Director's Message

Dear Cancer Center members,

SAVE THE DATES!

Fourth Annual Comprehensive Cancer Research Training Program
Monday, September 13 through Friday, September 17, 2010
Quadrus Conference Center
2700 Sand Hill Road
Menlo Park, CA


The CCRTP registration brochure includes details about the course, including registration instructions and form. The syllabus for the 2010 CCRTP is now available.

20th Anniversary Susan G. Komen San Francisco Race for the Cure
Sunday, September 26, 2010, at 8 am to 1 pm

Along the Embarcadero, starting and finishing at the Ferry Building.
For registration information about joining the Stanford Cancer Center team, visit our team site.

 

Congratulations to DCRA Recipients!
2010 Developmental Research Awards/Interactive Projects
2010 Developmental Cancer Research Awards in Translational and Population Sciences
http://cancer.stanford.edu/research/devresawds/2010DevResAwards.html


MORE KUDOS

Paul A. Khavari, MD, PhD, has been appointed chair of the department of
dermatology
in the Stanford University School of Medicine.

Khavari’s clinical interests focus on non-melanoma skin cancer. His research centers on gene regulation in homeostasis and cancer and on the development of new molecular therapeutics for skin disease. He is the recipient of the U.S. Presidential Early Career Award for Scientists and Engineers and the Shannon Award from the National Institutes of Health. He has also received the American Dermatological Association Young Leader Award, the American Academy of Dermatology Marion B. Sulzberger Award and the Society for Investigative Dermatology William Montagna Award and has been elected to American Society for Clinical Investigation and the American Association of Physicians.

Hongguang Liu, a postdoctoral fellow in the Cancer Molecular Imaging Chemistry Laboratory (CMICL), was awarded the MICoE Young Investigator Award (1st Place) for the paper presentation at the Annual Meeting of the Society of Nuclear Medicine (SNM 2010) in Salt Lake City for his talk on "Noninvasive Molecular Imaging of Radioactive Tracers Using Optical Imaging Techniques.” This work was also highlighted at the SNM Annual Meeting press conference as one of the top five research abstracts presented during the SNM meeting.

Other authors on that paper are: H. Liu, G. Ren, Z. Miao, X. Zhang, X. Tang, P. Han, S.S. Gambhir and Z. Cheng. The full article was published on PLoS One.

Four Cancer Center members were awarded about $5.6 million from the California Institute for Regenerative Medicine to study how to overcome the immune rejection of cells and tissues derived from stem cells:

Chris Contag, PhD, associate professor of pediatrics and of microbiology and immunology, received about $1.45 million to identify genes that, when expressed in embryonic stem cells from mice, allow the cells to be better tolerated by the recipient’s immune system. His team will use in vivo bioluminescence imaging to track the fate of stem cells labeled with luciferase in a living animal.

Robert Negrin, MD, professor of medicine and chief of Stanford University Medical Center’s blood and bone marrow transplant program, received about $1.4 million to study the ability of a type of immune cell called a regulatory T cell to protect embryonic stem cells from rejection. His team will study the ability of two distinct populations of regulatory T cells to control the rejection of the cells in mice.

Judith Shizuru, MD, associate professor of medicine, received about $1.4 million to study how to induce the body to accept transplants of purified blood stem cells, which do not cause graft-versus-host disease. In mice, the transplants cure autoimmune disease and induce tolerance to transplanted organs. Shizuru plans to devise ways to use similar techniques in human clinical trials.

Kenneth Weinberg, MD, the Anne T. and Robert M. Bass Professor in Pediatric Cancer and Blood Diseases, together with a collaborator at Monash University in Melbourne, Australia, received about $1.4 million to investigate whether inducing embryonic stem cells to become thymic epithelial cells, which are responsible for weeding out T cells that would attack the body’s own tissues, can prevent autoimmune diseases like multiple sclerosis and the rejection of other stem-cell-derived tissues.

Sincerely,

Bev

Beverly Mitchell Signature
Beverly S. Mitchell, MD
Director, Stanford Cancer Center

(July 2010 Director's Message)

Posted 07/22/10

Stanford Medicine Resources:

Footer Links: